Rosana Mussoi Bruno

Rosana Mussoi Bruno

Auto-generated profile, based on publicly available information

Rosana Mussoi Bruno

Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil; Santa Casa de Misericórdia de Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2003 in Transplantation Proceedings
Verified
Journal Article
Closed access
EKE Keitel
E Keitel
ASA.F Santos
A.F Santos
MAM.A Alves
M.A Alves
JNJ.P Neto
J.P Neto
PSP.G Schaefer
P.G Schaefer
VGV.D Garcia
V.D Garcia

1 June 2024 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
PDF file
EREloísa Radaelli
Eloísa Radaelli
GMGisele Meinerz
Gisele Meinerz
LJLázaro Pereira Jacobina
Lázaro Pereira Jacobina
RBRosana Mussoi Bruno
Rosana Mussoi Bruno
JAJuliana Alves Manhães de Andrade
Juliana Alves Manhães de Andrade
EKElizete Keitel
Elizete Keitel
Background: Kidney transplantation (KT) improves quality of life, including fertility recovery. Objective: to describe outcomes of post-KT pregnancy and long-term patient and graft survival compared to a matched control group of female KT recipients who did not conceive. Methods: retrospective single-center case-control study with female KT recipients from 1977 to 2016, followed-up until 2019. Results: there were 1,253 female KT patients of childbearing age in the study period: 78 (6.2%) pregnant women (cases), with a total of 97 gestations. The median time from KT to conception was 53.0 (21.5 – 91.0) months. Abortion rate was 41% (spontaneous 21.6%, therapeutic 19.6%), preterm delivery, 32%, and at term delivery, 24%. Pre-eclampsia (PE) occurred in 42% of pregnancies that reached at least 20 weeks. The presence of 2 or more risk factors for poor pregnancy outcomes was significantly associated with abortions [OR 3.33 (95%CI 1.43 – 7.75), p = 0.007] and with kidney graft loss in 2 years. The matched control group of 78 female KT patients was comparable on baseline creatinine [1.2 (1.0 – 1.5) mg/dL in both groups, p = 0.95] and urine protein-to-creatinine ratio (UPCR) [0.27 (0.15 – 0.44) vs. 0.24 (0.02 – 0.30), p = 0.06]. Graft survival was higher in cases than in controls in 5 years (85.6% vs 71.5%, p = 0.012) and 10 years (71.9% vs 55.0%, p = 0.012) of follow-up. Conclusion: pregnancy can be successful after KT, but there are high rates of abortions and preterm deliveries. Pre-conception counseling is necessary, and should include ethical aspects.

1 June 2024 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
PDF file
EREloísa Radaelli
Eloísa Radaelli
GMGisele Meinerz
Gisele Meinerz
LJLázaro Pereira Jacobina
Lázaro Pereira Jacobina
RBRosana Mussoi Bruno
Rosana Mussoi Bruno
JAJuliana Alves Manhães de Andrade
Juliana Alves Manhães de Andrade
EKElizete Keitel
Elizete Keitel
Resumo Histórico: Transplante renal (TR) melhora qualidade de vida, incluindo recuperação da fertilidade. Objetivo: descrever desfechos gestacionais pós-TR e sobrevida de longo prazo da paciente e do enxerto renal comparada a um grupo controle pareado de receptoras de TR que não conceberam. Métodos: estudo retrospectivo caso-controle com receptoras de TR de 1977 a 2016, acompanhadas até 2019. Resultados: foram identificadas 1.253 receptoras de TR em idade fértil no período do estudo: 78 (6,2%) gestantes (casos), total de 97 gestações. Tempo mediano entre TR até concepção foi 53,0 (21,5 – 91,0) meses. Taxa de aborto foi 41% (espontâneo 21,6%, terapêutico 19,6%), parto prematuro, 32%, e a termo, 24%. Pré-eclâmpsia (PE) ocorreu em 42% das gestações que alcançaram pelo menos 20 semanas. Presença de 2 ou mais fatores de risco para desfechos gestacionais desfavoráveis foi significativamente associada a abortos [OR 3,33 (IC95% 1,43 – 7,75), p = 0,007] e perda de enxerto renal em 2 anos. O grupo controle de 78 mulheres com TR foi comparável na creatinina basal [1,2 (1,0 – 1,5) mg/dL nos dois grupos, p = 0,95] e na relação proteína/creatinina urinária (RPCU) [0,27 (0,15 – 0,44) vs. 0,24 (0,02 – 0,30), p = 0,06]. Sobrevida do enxerto foi maior nos casos que nos controles em 5 anos (85,6% vs. 71,5%, p = 0,012) e 10 anos (71,9% vs. 55,0%, p = 0,012) de acompanhamento. Conclusão: a gestação pode ser bem-sucedida após TR, mas existem altas taxas de abortos e partos prematuros. Aconselhamento pré-concepção é necessário e deve incluir aspectos éticos.

21 January 2022 in medRxiv
Verified
Preprint
Open access
PDF file
EREloísa Radaelli
Eloísa Radaelli
GMGisele Meinerz
Gisele Meinerz
LJLázaro Pereira Jacobina
Lázaro Pereira Jacobina
RBRosana Mussoi Bruno
Rosana Mussoi Bruno
VGValter Duro Garcia
Valter Duro Garcia
EKElizete Keitel
Elizete Keitel
Introduction Kidney transplant is considered the method of choice in the treatment of end-stage chronic kidney disease, improving survival and quality of life, and often allowing the recovery of fertility among woman. Objective: This study aims to assess the outcomes of post-transplant pregnancy, newborn and patient graft survival, compared to a control group of transplanted women who weren’t pregnant. Methods A retrospective case-control study was conducted at the Kidney Transplant Service of Santa Casa de Misericórdia in Porto Alegre, among 1.253 female patients who underwent kidney transplantation and were of childbearing age between 1977 and 2016. They were compared to a control group matched for age, type of donor, date of transplant and immunological risk. Results 76 (6,1%) of the patients became pregnant, resulting in a total of 93 pregnancies. Compared to the control group, at 10 years after transplantation there was no significant difference in relation to graft loss (74% vs 66%, p=0.524), and the survival of pregnant patients was higher (97% vs 79%, p=0.018). We found that 40% pregnancies progressed to abortion, 30% of the deliveries were preterm, and 26% happened at term. Three pregnancies progressed to stillbirth. Of the 56 pregnancies that evolved, 23 (41%) resulted in pre-eclampsia, and one in eclampsia. Conclusion 6,1% of the women in the study became pregnant, and 56% of these pregnancies were successful. Compared to the control group, we found that those who got pregnant had similar graft survival outcomes and longer patient survival.